Molecular Products Group Announces Acquisition of the Henkel SODASORB Business
Monday 17th December 2018Molecular Products Group, (“Molecular Products” or the “Company”), a portfolio company of Arlington Capital Partners (“Arlington Capital”), today announced the acquisition of the SODASORB® business from a fully owned subsidiary of Henkel AG & Co. KGaA.
The SODASORB® product range includes carbon dioxide absorbents which have been trusted globally for decades in the healthcare and safety industries. SODASORB® products help to safely and efficiently remove carbon dioxide from anesthesia systems, saturation diving chambers, diving re-breathers, and industrial safety equipment.
Troy Rhudy, CEO of the Molecular Products Group, said, “We’re delighted to add the SODASORB® product line to our existing product portfolio. The new capacity will enhance our ability to respond to growing market demands and benefit our entire global customer base, while strengthening our position as the global leader in carbon dioxide absorbent technologies.”
“The acquisition of SODASORB® further establishes Molecular Products in the strategically important healthcare segment of the business, leveraging the Company’s core chemical technologies and expanding its capabilities,” said Peter Manos, Managing Partner of Arlington Capital Partners.
Malcolm Little, a Principal of Arlington, added, “This acquisition demonstrates Molecular Products’ continued focus on highly strategic M&A to expand the Company’s product offerings and enhance its capabilities across all of its segments.”
